RYSE Asset Management

RYSE Asset Management is a venture capital firm headquartered in London, specializing in early-stage (Seed and Series A) HealthTech investments. The firm focuses on transformative technologies in underserved areas to drive both impact and commercial returns, targeting unmet clinical needs and aiming to improve healthcare access and affordability. Its investment areas include digital diagnostics, digital therapeutics, medical devices, and data platforms, with expertise in cardiovascular health, metabolic disorders, oncology, mental health, women's health, and health AI. RYSE collaborates with industry partners like the NHS, Novartis, and Medtronic to help scale its portfolio companies. In March 2024, the firm announced the first close of a US$50 million Special Opportunities Fund.